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Increasing evidence highlights a role for the immune system in the
pathogenesis of autism spectrum disorder (ASD), as immune
dysregulation is observed in the brain, periphery, and gastroin-
testinal tract of ASD individuals. Furthermore, maternal infection
(maternal immune activation, MIA) is a risk factor for ASD.
Modeling this risk factor in mice yields offspring with the cardinal
behavioral and neuropathological symptoms of human ASD. In
this study, we ﬁnd that offspring of immune-activated mothers
display altered immune proﬁles and function, characterized by
a systemic deﬁcit in CD4+ TCRβ+ Foxp3+ CD25+ T regulatory cells,
increased IL-6 and IL-17 production by CD4+ T cells, and elevated
levels of peripheral Gr-1+ cells. In addition, hematopoietic stem
cells from MIA offspring exhibit altered myeloid lineage potential
and differentiation. Interestingly, repopulating irradiated control
mice with bone marrow derived from MIA offspring does not con-
fer MIA-related immunological deﬁcits, implicating the peripheral
environmental context in long-term programming of immune dys-
function. Furthermore, behaviorally abnormal MIA offspring that
have been irradiated and transplanted with immunologically nor-
mal bone marrow from either MIA or control offspring no longer
exhibit deﬁcits in stereotyped/repetitive and anxiety-like behav-
iors, suggesting that immune abnormalities in MIA offspring
can contribute to ASD-related behaviors. These studies support
a link between cellular immune dysregulation and ASD-related
behavioral deﬁcits in a mouse model of an autism risk factor.
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Autism is a complex neurodevelopmental disorder and apressing medical concern, affecting over 1% of children in
the United States (1). Although autism spectrum disorder (ASD)
is characterized by stereotypic behaviors and language and social
deﬁcits, increasing evidence suggests a role for the immune
system in ASD pathogenesis. Altered cytokine proﬁles in the
postmortem brain, cerebrospinal ﬂuid, and plasma are found in
ASD, and several studies have demonstrated an elevated number
and activation of microglia and astrocytes in the postmortem
brain (2). There are also many reports of peripheral immune
abnormalities in autistic individuals, including increased NK cell
activity, differential monocyte responses to in vitro stimulation,
and altered serum Ig levels (3, 4).
Abnormal activation of the immune system may also be in-
volved in the etiology of autism. Several studies have associated
ASD risk with immune-related susceptibility genes, such as those
encoding MET receptor tyrosine kinase, PRKCB1, complement
C4B, and speciﬁc HLA haplotypes (3, 4). In addition, antibrain
antibodies are elevated in some ASD sera and in some mothers of
autistic children (5–7). Family members of autistic children, par-
ticularly the mothers, show a higher incidence of allergy or auto-
immune diseases (8, 9). Consistent with immune involvement are
ﬁndings that maternal infection is a risk factor for autism (2).
After the 1964 rubella pandemic, 8–13% of children born to
infected mothers developed features of autism (10). In a recent
study surveying all children born in Denmark from 1980 to 2005,
a very signiﬁcant association was found between autism and ma-
ternal viral infection during the ﬁrst trimester of pregnancy (11).
Moreover, elevation of IFN-γ, IL-4, or IL-5 in maternal serum is
associated with increased risk for ASD in the offspring (12), as is
elevation of monocyte chemoattractant protein-1 in the amniotic
ﬂuid (13).
Whether the immune abnormalities in ASD actually contribute
to its behavioral symptoms or whether they are an epiphenome-
non of primary neural dysfunction is an outstanding question. The
immune system exhibits lifelong reciprocal interactions with the
central nervous system, and the fact that the immune status can
inﬂuence behavioral responses is exempliﬁed by early studies
demonstrating that responses to infection and inﬂammation are
relayed to the brain, resulting in the induction of fever and sick-
ness behavior (14). Moreover, administration of certain cytokines
to human subjects frequently causes striking changes in mental
state (15). Conversely, emotional and psychological state can in-
ﬂuence immune function. Perhaps the strongest evidence to date
is the ﬁnding that both short- and long-term stress lead to dis-
ruption of immune function (16). Immune dysregulation has also
been implicated in the etiology of a variety of neurodegenerative,
psychiatric, and neurodevelopmental disorders, including Parkin-
son, Huntington, and Alzheimer’s diseases, multiple sclerosis,
major depression, schizophrenia, and addiction (17–20).
Here we ask whether a mouse model exhibiting many features
of autism also displays altered immune function. We use the
maternal immune activation (MIA) model, which is based on
maternal infection as a key environmental risk factor for autism.
Pregnant mice are injected with the synthetic, double-stranded
RNA, poly(I:C), to initiate a proinﬂammatory antiviral response.
This type of MIA yields offspring with the core behavioral and
neuropathological symptoms of autism, including reduced social
interaction, abnormal communication, stereotyped/repetitive be-
havior, and a spatially restricted deﬁcit in Purkinje cells (21, 22).
In this study, we proﬁle peripheral immune subtypes, assess
the functional activities of major leukocyte lineages and evaluate
the lineage potential of fetal and adult hematopoietic stem cells
(HSCs) and progenitors. To explore the potential for prenatal
programming of long-term immune dysfunction, we examine
whether transferring HSCs from MIA offspring into non-MIA
offspring can induce cell-autonomous immune abnormalities. To
gain insight into whether immune abnormalities in MIA off-
spring contribute to the pathogenesis of ASD-related behaviors,
we behaviorally assess poly(I:C) offspring repopulated with bone
marrow (BM) from saline offspring. Our ﬁndings demonstrate
that immune challenge during prenatal life leads to persistent
immune alterations in the postnatal offspring, which can further
impact the development or maintenance of abnormal behavior.
Results
MIA Offspring Exhibit Deﬁcits in Regulatory T Cells and Elevated CD4+
T-Cell Responses.Many studies of immune dysregulation in human
ASD report a bias toward a proinﬂammatory phenotype (3, 4).
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We therefore investigated regulatory T cells (Tregs) as known
suppressors of the innate and adaptive immune responses.
Compared with controls, adult offspring of poly(I:C)-injected
mothers display a ∼50% decrease in splenic CD4+ Foxp3+
CD25+ Tregs (Fig. 1A). This deﬁcit is also reﬂected in signiﬁ-
cantly decreased levels of total CD4+ Foxp3+ cells and possible
decreases (P = 0.0846) in CD4+ Foxp3+ CD25− T cells. Similar
deﬁcits in total CD4+ Foxp3+, Foxp3+ CD25−, and Foxp3+
CD25+ cells are also observed in mesenteric lymph nodes
(MLNs) from adult poly(I:C) offspring (Fig. S1A). Despite these
differences in Treg levels, there is no difference in the suppres-
sion of CD4+CD25− T-cell proliferation between Tregs from
saline versus poly(I:C) offspring (Fig. S2). Taken together, these
ﬁndings indicate a systemic deﬁcit in the abundance of Tregs.
We further tested MIA offspring for levels of IL-17–producing
CD4+ T (Th17) cells, given their proinﬂammatory nature and
reported reciprocal relationship with Tregs. In assays done in
parallel with those for Tregs, we ﬁnd no signiﬁcant difference
from controls in levels of CD4+ TCRβ+ IL-17+ (Th17) cells,
with or without IFN-γ expression (Fig. 1B). There is also no
difference in the level of CD4+ TCRβ+ IL-17− IFN-γ+ (Th1)
cells. To further examine CD4+ T cells, we measured their se-
cretion of IL-6 and IL-17 in response to in vitro stimulation.
Compared with controls, CD4+ cells from spleens of 15-wk-old
poly(I:C) offspring release signiﬁcantly more IL-6 and IL-17
after in vitro stimulation, with no difference in TNF-α secretion
(Fig. 1C). This result is similarly observed with splenic CD4+
T cells derived from 3-wk-old offspring (Fig. S3A) and 1-y-old
offspring (Fig. S3B), suggesting an early onset of persistent im-
mune dysfunction. Interestingly, splenic CD4+ T cells from 3-wk-
old mice produce much lower levels of IL-17 than do such cells
from adult offspring (0–10 pg/mL compared with 50–400 pg/
mL), reﬂecting the immunological immaturity reported in young
versus adult mice and humans (23). CD4+ T cells from MLNs of
poly(I:C) offspring are also hyperresponsive to in vitro stimula-
tion, suggesting that this abnormality is common to secondary
lymphoid organs (Fig. S1 C and D). Overall, MIA leads to lower
Treg levels and elevated CD4+ T-cell responsiveness in spleens
and MLNs from MIA offspring. This result can be characterized
as a persistent, proinﬂammatory T-helper-cell phenotype.
MIA Offspring Display Increased Levels of Gr-1+ Cells and Skewed HSC
Differentiation. To determine whether MIA during fetal de-
velopment alters the proﬁle of other immune subtypes in the
offspring, we assessed major leukocyte classes in spleens from
poly(I:C) and saline offspring. Compared with controls, adult
poly(I:C) offspring exhibit a 1.5-fold higher level of Gr-1+ cells
and trending increase in CD11b+ cells (P = 0.1256) (Fig. 2A). In
contrast, there is no difference from controls in the percentages
of total B220+ B cells, NK1.1+ NK cells, CD4+ T cells, or CD8+
T cells. Moreover, no signiﬁcant differences are detected for any
of the primary leukocyte subtypes in the MLNs (Fig. S1B).
Gr-1+ cells reﬂect a heterogeneous group of immune subtypes
that includes neutrophils and monocytes, inﬂammatory cells, and
suppressor cells, alike. To determine whether the elevated levels
of Gr-1+ cells observed in poly(I:C) spleens could be attributed
to particular Gr-1+ subtypes, we further characterized the
splenic Gr-1+ population using CD11b, Ly6C, and Ly6G mark-
ers. Interestingly, poly(I:C) offspring exhibit mild increases in all
three populations of Gr-1+ cells resolved: (i) Gr-1hi CD11b+
Ly6Cmid Ly6Ghi SSCmid, (ii) Gr-1mid CD11b+ Ly6Cmid Ly6Gmid
SSCmid, and (iii) Gr-1mid CD11b+ Ly6Chi Ly6G- SSClo (Fig. S4).
Gr-1+ subtypes i and ii are referred to as neutrophils, by his-
tology and in line with their high granularity, and subtype iii is
identiﬁed as a monocyte population (24). Overall, that poly(I:C)
offspring display increases in all identiﬁed Gr-1+ populations
suggests that skewing at the HSC or progenitor level may un-
derlie the elevated Gr-1 phenotype observed in adult poly(I:C)
offspring compared with controls.
To evaluate the origin of the increase in splenic Gr-1+ cells,
we assessed the lineage potential and differentiation of BM cells
from adult poly(I:C) versus saline offspring. Using a colony-
forming assay to morphologically assess lineage differentiation,
we ﬁnd that HSCs and progenitors from poly(I:C) offspring BM
exhibit increased differentiation into CFU-G (granulocyte) pre-
cursors and decreased differentiation into early CFU-GM
(granulocyte-macrophage) precursors (Fig. 2B). Turning to the
fetus, we ﬁnd that similar differentiation is observed with fetal
liver HSCs and progenitors from poly(I:C) offspring (Fig. 2C).
Thus, MIA induces preferential differentiation of fetal as well as
adult HSCs and progenitors into granulocyte precursors, which
may account for the increased levels of mature Gr-1+ cells in
spleens of poly(I:C) offspring compared with controls.
Immune Abnormalities Observed in MIA Offspring Are Not Transferred
via BM Transplant. Our data demonstrate that MIA leads to an
altered proﬁle of peripheral immune cells in the offspring,
characterized by decreased levels of Tregs, hyperresponsive
CD4+ T cells, and elevated levels of Gr-1+ cells. To explore
whether these immune abnormalities (and the Gr-1 phenotype,
in particular) can be attributed to cell-intrinsic developmental
programming of HSCs, we transferred BM from the immuno-
logically aberrant poly(I:C) offspring into irradiated saline and
Fig. 1. MIA leads to decreased levels of
Tregs and hyperresponsiveness in CD4+ T cells
from spleens of adult offspring. (A) Com-
pared with controls, adult poly(I:C) offspring
exhibit decreased levels of CD4+ Foxp3+
splenocytes and CD4+ Foxp3+ CD25+ Tregs
(n = 5, where each sample represents a pool
of three spleens). (B) Adult poly(I:C) offspring
exhibit decreased levels of splenic CD4+
TCRβ+ Foxp3+ CD25+ Tregs, but no signiﬁcant
difference in splenic CD4+ TCRβ+ IFN-γ+ IL-17+
Th17+ Th1 cells or CD4+ TCRβ+ IFN-γ− IL-17+
Th17 cells (n = 4, where each sample repre-
sents a pool of three spleens). (C) CD4+ T cells
from the spleens of adult offspring secrete
elevated levels of IL-6 and IL-17 in response
to PMA/ionomycin stimulation. In contrast,
CD4+ T cells from spleens of adult poly(I:C)
and saline offspring do not differ the level
of TNF-α secreted (n = 11–16). *P < 0.05,
**P < 0.01, ***P < 0.001; n.s., not signiﬁcant.
All panels show one representative experi-
ment of at least two separate trials.
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poly(I:C) offspring and assessed whether any MIA-associated
immune abnormalities were reestablished.
We ﬁnd that saline and poly(I:C) offspring that were irradi-
ated and reconstituted with poly(I:C) BM do not develop or
retain any of the immune abnormalities exhibited by un-
manipulated MIA offspring. All BM-transplanted groups exhibit
levels of splenic CD4+ TCRβ+ CD25+ Foxp3+ Tregs and Gr-1+
cells that are comparable to those observed in untransplanted
saline offspring (Fig. 3 A and B). There is also no difference
between saline and BM-transplanted mice in distributions of
progenitor subtypes after in vitro differentiation of BM HSCs
(Fig. S5). Furthermore, CD4+ T cells isolated from spleens of
any of the types of BM-transplanted mice secrete levels of IL-6
and IL-17 in response to phorbol 12-myristate 13-acetate
(PMA)/ionomycin stimulation that are similar to those produced
by CD4+ T cells isolated from spleens of untransplanted saline
offspring (Fig. 3C). Importantly, the fact that saline mice trans-
planted with saline BM display equivalent levels of Tregs and
Gr-1+ cells and similar CD4+ T-cell responsiveness to those
observed in unmanipulated saline offspring suggests that the ir-
radiation and BM-transplant procedure itself does not skew
immune system proﬁles under these conditions. Overall, these
experiments indicate that MIA-associated immune abnormalities
are not transferred via transplant of poly(I:C) BM into irradiated
saline or poly(I:C) offspring. This ﬁnding suggests either that the
HSC microenvironment is important for maintaining altered
HSC potential in MIA offspring, or that the particular MIA-
associated immune abnormality is not programmed at the stem
cell level.
BM Transplant in MIA Offspring Normalizes Repetitive and Anxiety-
Like Behavioral Abnormalities. To investigate whether the immune
abnormalities found in MIA offspring are an independent par-
allel pathology or if they actually contribute to the development
or maintenance of ASD-like behaviors, we assessed behavioral
performance in poly(I:C) offspring transplanted with saline BM.
Poly(I:C) offspring were ﬁrst conﬁrmed to exhibit their expected
behavioral phenotypes before the procedure. Compared with
controls, poly(I:C) offspring display a deﬁcit in prepulse in-
hibition (PPI) (Fig. S6A). PPI is used to measure sensorimotor
gating of the startle reﬂex, and decreased PPI is frequently ob-
served in autistic individuals (25). Poly(I:C) offspring also exhibit
core behavioral symptoms of autism, including increased re-
petitive behavior as measured by higher levels of stereotypic
marble burying and decreased social preference, as assessed by
reduced duration spent and entries into a chamber housing
a novel mouse versus a familiar mouse (Fig. S6 B and C). In
addition, MIA offspring exhibit increased anxiety, as reﬂected by
Fig. 2. MIA leads to increased levels of splenic Gr-1+ cells
in adult offspring and preferential differentiation of HSCs
into granulocyte precursors in fetal and adult offspring.
(A) Spleens from adult poly(I:C) offspring exhibit in-
creased levels of Gr-1+ cells and no signiﬁcant differences
in other major lineages compared with controls (n = 4,
where each sample represents a pool of three spleens). (B)
Compared with BMHSCs from control offspring, BMHSCs
from adult poly(I:C) offspring display increased differen-
tiation into CFU-G precursors and decreased differentia-
tion into early CFU-GM precursors (n = 4). Compared with
controls, fetal liver HSCs from embryonic day (E) 13.5 (C,
Left) and E15.5 (C, Right) poly(I:C) offspring also display
increased differentiation into CFU-G and decreased dif-
ferentiation into CFU-GM, in addition to decreased per-
centages of CFU-GEMM with E13.5 HSCs and increased
percentages of CFU-E with E15.5 HSCs (n = 4, where each
sample represents a pool of cells from six fetal livers from
a single litter). *P < 0.05, **P < 0.01, ***P < 0.001; n.s.,
not signiﬁcant. All panels represent one representative
experiment of at least two separate trials.
Fig. 3. Immune abnormalities observed in MIA offspring
are not transferred by BM transplant into irradiated mice.
(A) There is no difference in levels of splenic CD4+ TCRβ+
CD25+ Foxp3+ Tregs between saline or poly(I:C) offspring
transplanted with BM from saline or poly(I:C) offspring.
Levels of splenic Tregs between BM transplant groups are
comparable to those observed in untransplanted saline
offspring; untransplanted poly(I:C) offspring display a sig-
niﬁcant deﬁcit in Treg percentages (n = 4–5). (B) BM-
transplanted mice do not display MIA-associated increases
in splenic Gr-1+ cells. Percentages of Gr-1+ cells are com-
parable between BM transplanted groups and untrans-
planted saline offspring (n = 4–5), but untransplanted poly
(I:C) offspring exhibit signiﬁcantly elevated levels of splenic
Gr-1+ cells. (C) CD4+ T cells from BM-transplanted mice
exhibit statistically equivalent levels of IL-6 (Left) and IL-17
(Right) in response to PMA/ionomycin stimulation in vitro.
There are no differences between concentrations of IL-6
and IL-17 secreted by CD4+ cells from BM-transplanted
groups and from untransplanted saline offspring, despite
signiﬁcant hyperresponsiveness of CD4+ T cells from poly(I:
C) offspring [n = 11–16 for saline and poly(I:C) groups, 4–5
for BM transplant groups]. *P < 0.05, **P < 0.01. BM
transplant data were acquired from one large experiment.
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reduced duration spent, and entries into, the center arena of an
open ﬁeld, despite no signiﬁcant difference in total distance
traveled (Fig. S6D).
After this initial behavioral testing, the mice were irradiated
and transplanted with donor BM harvested from either adult
saline or poly(I:C) offspring. Notably, mouse heads were shiel-
ded during the procedure to limit known effects of irradiation on
neurogenesis and glial activation, and to preclude any associated
downstream inﬂuences on behavioral performance. Further-
more, MIA offspring do not exhibit global changes in levels of
activated or total brain macrophages/microglia (Fig. S7), sug-
gesting that microglial abnormalities do not contribute the
persistence of ASD-related behaviors in these mice.
After irradiation and transplantation with saline BM, MIA
offspring no longer exhibit behavioral abnormalities in several of
these tests. Irradiation and saline BM transplant in poly(I:C)
offspring restores repetitive marble burying to levels observed in
saline controls (Fig. 4A). In addition, irradiated and BM-trans-
planted MIA offspring exhibit signiﬁcantly decreased anxiety-like
behavior, as measured by elevated duration of time spent
and entries into the center arena of the open ﬁeld (Fig. 4B).
Interestingly, both saline and poly(I:C) BM-transplanted mice
exhibit signiﬁcantly increased number of center entries compared
with untransplanted offspring. This ﬁnding is similarly reﬂected by
a statistically signiﬁcant increase in total distance traveled by
transplanted offspring versus untransplanted controls. This ﬁnding
may be a result of effects of the irradiation and transplant pro-
cedure on behavior rather than habituation of the mice to re-
peated testing, because we are able to replicate open ﬁeld deﬁcits
of equivalent intensity in poly(I:C) offspring after retesting at
different adult ages (Fig. S8). On the other hand, treatment of
poly(I:C) offspring with saline BM has no signiﬁcant effect on the
deﬁcit in social preference, as measured by duration and number
of entries into the social chamber (Fig. 4C).
Although treatment of MIA offspring with irradiation and
saline BM transplantation signiﬁcantly restores normal behavior
in several tests, we ﬁnd that treatment of MIA offspring with
irradiation and poly(I:C) BM transplantation also improves
those behaviors. Notably, irradiated MIA offspring transplanted
with poly(I:C) BM exhibit improved open ﬁeld and marble-
burying performance (Fig. S9). This result is consistent with our
ﬁnding that transplant of poly(I:C) BM does not give rise to cell-
autonomous immune abnormalities (Fig. 3). As such, both poly
(I:C) BM and saline BM can be considered immunologically
normal in these experiments. Taken together, these data dem-
onstrate that MIA offspring that had previously exhibited ab-
normal behaviors fail to exhibit repetitive and anxiety-like
behavior after exposure to irradiation and BM transplant.
Discussion
In the present study we identify differences in dynamic cellular
immune responses in a mouse model of an autism risk factor.
Offspring of immune-activated mothers develop altered immune
proﬁles and function in the spleen and MLN, which are consis-
tent with a proinﬂammatory phenotype. In addition, we dem-
onstrate preferential myeloid differentiation of fetal HSCs and
progenitors, which is also found in adult HSCs. This ﬁnding
could form the basis for the altered immune distributions in
secondary lymphoid organs from MIA offspring. However, BM
transplant of HSCs derived from MIA offspring is not sufﬁcient
to recapitulate the elevated levels of Gr-1+ cells exhibited by
untransplanted MIA offspring. This result highlights the impor-
tance of appropriate environmental cues for preserving this
phenotype, as discussed below. We also used the irradiation-BM
transplant approach to explore the role of peripheral immune
dysfunction on behavioral performance. Interestingly, this pro-
cedure corrects some of the ASD-like behavioral symptoms in
the MIA offspring.
MIA leads to permanently hyperresponsive CD4+ T cells, as
well as decreased Tregs in the offspring, suggesting a chronic,
proinﬂammatory phenotype. This ﬁnding is consistent with de-
creased numbers CD4+ CD25+ and CD3+GITR+ T cells ob-
served in children with ASD (26, 27). Diminished Treg levels and
associated decreases in immune regulation may reﬂect the
ﬁnding that autistic individuals exhibit decreased levels of regu-
latory cytokines, such as TGF-β1, and increased levels of
proinﬂammatory cytokines in serum, cerebrospinal ﬂuid and
postmortem brain (2). Furthermore, given that Tregs are critical
for limiting immune activation and preventing self-reactivity,
their deﬁciency may underlie the reports of a link between ASD
and autoimmune disease (8, 28).
Our ﬁnding that CD4+ T cells from MIA offspring are hyper-
responsive to in vitro stimulation further reﬂects diminished
immune homeostasis. Increases in activated DR+ T cells are ob-
served in human autism (29, 30). In addition, elevated levels of
TNF-α– and IFN-γ–producing T cells are found in peripheral
blood and gastrointestinal mucosa from autistic individuals (31). A
number of other altered immune responses have been reported in
ASD (3, 4), and we ﬁnd that MIA offspring also exhibit some of
these changes, including altered leukocyte subsets and CD4+
T-cell responses to stimulation. This overlap between ﬁndings of
immune dysregulation in ASD and our current results lends sup-
port to MIA as a mouse model with construct and face validity for
this disorder.
We further demonstrate that MIA during fetal development
leads to signiﬁcantly increased levels of peripheral Gr-1+ CD11b+
neutrophilic and monocytic cells in adult offspring. Granulocytosis
Fig. 4. MIA offspring irradiated and transplanted with
saline BM exhibit decreased repetitive and anxiety-like
behavior. (A) Irradiation and transplantation of saline BM
into MIA offspring restores repetitive marble-burying be-
havior to a level at or below that observed in controls. (B)
Irradiation and transplantation of saline BM into MIA off-
spring decreases anxiety-like behavior as measured by sig-
niﬁcant increases in the number of center entries (Center)
and duration in the center arena (Left), compared with
those observed in untransplanted MIA mice. Both saline
and poly(I:C) BM-transplant mice also exhibit increased
overall activity in the open ﬁeld, as measured by signiﬁ-
cantly increased total distance traveled compared with
untransplanted mice (Right). (C) Transplanting saline off-
spring BM into poly(I:C) offspring has no signiﬁcant effect
on their social preference behavior, as measured by cham-
ber duration (Left). There is, however, a trending im-
provement in social preference behavior as measured by
chamber frequency in BM-transplanted MIA offspring
(Right). *P < 0.05, **P < 0.01; n.s., not signiﬁcant. BM-
transplant data were acquired from one large experiment.
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is typically observed after acute inﬂammation (32, 33) and is also
a feature of a number of chronic diseases (34–36). There have
been no reports of altered neutrophil levels in ASD, however. In
one study, children with ASD exhibited increased plasma mono-
cyte counts, but no signiﬁcant abnormalities in major granulocyte
subtypes (37). In light of the present results, it will be of interest
to extend these immunophenotypic studies to behavioral or
symptomatic subpopulations of ASD individuals.
It is intriguing to consider that MIA effects on developing
HSCs may underlie some of the persistent peripheral immune
changes found in the offspring. We ﬁnd that both adult and fetal
HSCs and progenitor cells display preferential differentiation
into CFU-G colonies, which provides an explanation for how
increases in such short-lived cells could be maintained over the
lifespan of MIA offspring. Maternal poly(I:C) injection is known
to induce dramatic increases in proinﬂammatory cytokines in the
placenta, a principal HSC niche during midgestation (38). Be-
cause HSCs and progenitors respond to inﬂammatory signals,
such as cytokines and Toll-like receptor ligands, it will be in-
teresting to explore whether MIA-induced changes in the HSC
environment can skew hematopoietic lineage decisions and fate.
Despite the fact that HSCs and progenitors isolated from poly
(I:C) offspring are developmentally skewed toward granulocyte
precursors, transplantation of BM from poly(I:C) offspring into
irradiated saline offspring or back into irradiated poly(I:C) off-
spring does not transfer the Gr-1 phenotype. This ﬁnding sug-
gests that developmental programming of HSCs to skew lineage
differentiation in MIA offspring is not governed solely by stably
encoded cell-intrinsic factors, such as epigenetic modiﬁcation.
Rather, it is likely that an MIA-induced peripheral environment
is necessary to supply the cues that guide preferential myeloid
development. Changes in G-CSF, IL-5, and IL-3 levels, for ex-
ample, are implicated in ﬁne-tuning the transcription factor ac-
tivity that governs lineage choice for granulocyte/macrophage
progenitors (39). Indeed, we have found that MIA offspring
exhibit dynamic and chronically altered peripheral blood and
splenic cytokine proﬁles (40). It will be of interest to assess
whether the BM microenvironment differs in poly(I:C) and sa-
line offspring. Overall, it is intriguing that the Gr-1 phenotype
observed in MIA offspring is not transferred via BM transplant,
suggesting a lack of sufﬁcient cell-intrinsic epigenetic pro-
gramming and a key role for environmental factors in promoting
this lineage choice.
We demonstrate that subjecting MIA offspring that have
validated behavioral deﬁcits to irradiation and reconstitution
with immunologically normal BM alters their behavioral phe-
notype. Namely, these MIA offspring no longer exhibit their
previous abnormalities in repetitive marble burying and open-
ﬁeld exploration. These ﬁndings imply that correcting immune
function can correct some autism-related behavioral abnormal-
ities. However, this experiment has a signiﬁcant limitation. In the
absence of a positive control (MIA offspring that retain behav-
ioral deﬁcits after irradiation and BM transplantation), we are
unable to distinguish between the potential restorative effects of
the BM itself (that is, the effects of restoring immune phenotype)
versus the effect of confounding factors associated with the
transplant procedure. The most obvious of these is the effect of
irradiation on various aspects of recipient homeostasis, including
metabolic function, gastrointestinal microbial composition, and
oxidative stress, all of which may indirectly inﬂuence behavioral
outcome. We are, however, inspired by recent work demon-
strating that stereotyped grooming behavior in Hoxb8 mutant
mice is, in fact, transferrable via BM transplant (41). This ﬁnding
shows, at least in that experimental model, that mice can re-
constitute an expected behavioral impairment via BM transplant
despite prior irradiation. It will be important to explore other
experimental approaches to treat immune dysfunction in MIA
offspring and to further assess whether these can alleviate
behavioral outcomes.
Nonetheless, our ﬁnding that behavioral abnormalities in the
MIA offspring can be corrected by the irradiation-BM transplant
procedure contributes to a growing number of studies reporting
the efﬁcacy of BM transplant on ameliorating symptoms of
neurological disorders (41–43). Furthermore, several experi-
ments using RAG1 KO, SCID, and athymic mice demonstrate
that primary immune dysfunction can lead to behavioral im-
pairment (44–47). Interestingly, work with germ-free mice links
the absence of microbiota and associated alterations in the im-
mune system to abnormal behavioral performance (48). Some
immune alterations have been described in the maternal valproic
acid model and the BTBR mouse strain that display behavioral
features of autism (49, 50). In contrast, much remains to be
learned about potential immune changes in mouse models of
ASD candidate genes. One such gene is particularly attractive in
this regard, MET, which encodes a tyrosine kinase receptor and
is known to play a role in immune regulation (51).
Altered peripheral immune proﬁles and cellular activity are
also associated with core behavioral impairments in human ASD.
Increased plasma IL-4 levels correlate with greater deﬁcits in
communication, and increased plasma IL-8, IL-12p40, IL-6, and
IL-1β are linked to stereotypy, hyperactivity, and lethargy scores
from ASD children (52). Altered levels of other immune factors,
including TGF, macrophage migration inhibitory factor (MIF),
and CD31, have also been associated with the severity of ASD-
related behaviors or pathophysiology (4). In addition, reduced
levels of plasma IgG and IgM are associated with behavioral
severity in ASD children (53).
It is striking that in a mouse model of an autism environmental
risk factor that exhibits the cardinal behavioral and neuropatho-
logical symptoms of autism, there is also permanent peripheral
immune dysregulation. This ﬁnding provides the opportunity to
explore molecular mechanisms underlying the relationship be-
tween brain dysfunction and altered immunity in the manifestation
of abnormal behavior. Furthermore, this ﬁnding provides a plat-
form for investigating how prenatal challenges can program
long-term postnatal immunity, health, and disease. Maternal in-
sult-mediated epigenetic modiﬁcation in HSC and progenitor cells
is one possible mechanism for how effects may be established by
transient environmental changes yet persist permanently into
adulthood. However, the BM transplant results suggest that the
peripheral environment of the MIA offspring is also critical for
maintaining a permanently modiﬁed immune state.
Methods
Detailed methods are provided in SI Methods.
MIA. Pregnant C57BL/6Nmicewere injected onE12.5with saline or poly(I:C). For
poly(I:C) injections, poly(I:C) potassium salt (Sigma Aldrich) was dissolved in
saline at 4mg/mL and administered intraperitoneally at 20mg/kg [based on the
weight of the poly(I:C) itself, not including the total weight of the potassium
salt]. Control mice were injected with saline alone at 5 μL/g body weight.
CD4+ T-Cell in Vitro Stimulation. 106 CD4+ T cells were cultured in complete
RPMI with PMA (50 ng/mL) and ionomycin (750 ng/mL) for 3 d at 37 °C with
5% (vol/vol) CO2. Each day, 0.5 mL supernatant was collected. ELISA to de-
tect IL-6, IL-17, and TNF-α were performed according to the manufacturer’s
instructions (eBioscience).
Flow Cytometry. For subtyping of Gr-1+ splenocytes, cells were stained with
Gr-1-APC, CD11b-PE, Ly6G-APC, Ly6C-FITC, and Ter119-PerCP-Cy5.5 (Biol-
egend). For detection of Th17 cells and Tregs, splenocytes were stimulated
for 4 h with PMA/ionomycin in the presence of GolgiPLUG (BD Biosciences).
Suspensions were blocked for Fc receptors and labeled with CD4-FITC, TCRb-
PerCP-Cy5.5, and CD25-PE before labeling with IFN-γ–PE and Foxp3-APC
(eBioscience). Samples were processed using the FACSCalibur cytometer (BD
Biosciences). Data were analyzed using FlowJo software (TreeStar).
Methylcellulose Colony-Forming Assay. 2 × 105 fetal liver or BM cells were
added to 3 mL of thawed methylcellulose supplemented with SCF, IL-3, IL-6,
and Epo (StemCell). Total colony number was counted on day 5 and conﬁrmed
to be equivalent across groups. CFU-G, -M, -E (erythroid), -GM, and -GEMM
colonies were blindly scored on day 12 according to standard protocols.
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BM Transplantation. Behaviorally tested, 9-wk-old mice were injected in-
traperitoneally with high-dose ketamine/xylazine (5.6 μL/1 g per mouse) and
lethally irradiated (1,000 rads) with heads shielded by 4-mm lead. The ef-
fectiveness of the head shields was conﬁrmed by selective graying of black
coat color in the irradiated area. Recovered mice were anesthetized with
isoﬂuorane and injected retro-orbitally with 5 × 106 donor BM cells. Mice
were retested in behavioral paradigms at 17–19 wk of age and killed for
immunological assays at 19–20 wk of age.
Behavioral Testing. At 6–8 wk of age, mice were behaviorally tested for PPI,
open-ﬁeld exploration, repetitive marble burying, and social preference (22,
38, 54, 55). Eight weeks after transplant, mice were similarly tested in all
paradigms but PPI because PPI performance is highly sensitive to handling
and prior testing experience (56).
Statistical Analysis. Statistical analysis was performed with Prism software
(Graphpad). Differences between two treatment groups were assessed using
Student t test, and differences among multiple groups were assessed using
one-way ANOVA and Bonferroni post hoc test. Two-way ANOVA and Bon-
ferroni post hoc test was used for PPI, CD4+ T-cell stimulation and methyl-
cellulose assay data.
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